XML 23 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Goodwill and Intangible Assets
6 Months Ended
Jul. 03, 2015
Goodwill [Line Items]  
Goodwill and Intangible Assets
Goodwill and Intangible Assets:
The Company's National Security Solutions ("NSS") and Health and Engineering ("HES") reportable segments contain goodwill. The balance and changes in the carrying amount of goodwill by segment were as follows:
 
NSS
 
HES
 
Total
 
(in millions)
Goodwill at January 31, 2014
$
788

 
$
905

 
$
1,693

Goodwill impairment charges

 
(486
)
 
(486
)
Goodwill at January 30, 2015
$
788

 
$
419

 
$
1,207

Adjustments

 

 

Goodwill at July 3, 2015
$
788

 
$
419

 
$
1,207


Goodwill is tested for impairment at the reporting unit level annually, at the beginning of the fourth quarter, and during interim periods whenever events or circumstances indicate that the carrying value may not be recoverable. There were no goodwill impairments during the six months ended July 3, 2015.
During the second quarter ended August 1, 2014, as part of its normal quarterly procedures, the Company considered both qualitative and quantitative factors associated with each of the Company's reporting units and determined that there were indicators that the carrying values of the Health Solutions and Engineering reporting units may not be fully recoverable due to operating performance shortfalls and forecasted declines of revenues and operating income. Based on the unexpected impacts, the Company conducted an interim goodwill impairment test using the two-step quantitative approach.
The Company utilized both the market and income approach as part of the first step of the two-step quantitative goodwill impairment test to determine the estimated fair value of both the Health Solutions and Engineering reporting units (Level 3 fair value measurement).
Based on the first step of the two-step quantitative goodwill impairment test, the Company determined that the fair values of the Health Solutions and Engineering reporting units were below their carrying values. Due to the fact that indicators of impairments existed, the second step of the two-step quantitative goodwill impairment test was performed to determine the implied fair value of goodwill and the impairment amount of the respective reporting units.
As a result of the second step evaluation, the Company recorded goodwill impairment charges in the Health Solutions and Engineering reporting units of $369 million and $117 million, respectively, for the quarter ended August 1, 2014, which represents the difference between the carrying value and the implied fair value. There were no other goodwill impairment charges recorded for the remaining reporting units. No goodwill impairments were identified as part of the Company's annual goodwill impairment evaluation performed in the prior year.
Intangible assets consisted of the following:
 
July 3, 2015
 
January 30, 2015
 
Gross carrying value
 
 Accumulated amortization
 
Net carrying value
 
Gross carrying value
 
Accumulated amortization
 
Net carrying value
 
(in millions)
Finite-lived intangible assets:

 

 

 

 

 

Customer relationships
$
70

 
$
(60
)
 
$
10

 
$
70

 
$
(57
)
 
$
13

Software and technology
61

 
(43
)
 
18

 
52

 
(41
)
 
11

Total finite-lived intangible assets
131

 
(103
)
 
28

 
122

 
(98
)
 
24

Indefinite-lived intangible assets:


 


 


 


 


 


In-process research and development

 

 

 
9

 

 
9

Trade names
4

 

 
4

 
4

 

 
4

Total indefinite-lived intangible assets
4

 

 
4

 
13

 

 
13

Total intangible assets
$
135

 
$
(103
)
 
$
32

 
$
135

 
$
(98
)
 
$
37


The gross carrying value of finite-lived intangible assets increased from January 30, 2015 due to the addition of an in-process research and development intangible asset that reached technological feasibility and began amortizing as a software and technology intangible asset over its useful life of nine years.
Amortization expense related to amortizable intangible assets was $3 million and $5 million for the quarter and six months ended July 3, 2015, respectively, and $5 million and $10 million for the quarter and six months ended August 1, 2014, respectively.
For the quarter ended August 1, 2014, the Company determined that certain customer relationship intangible assets associated with Vitalize and maxIT were not recoverable due to lower projected revenue and operating income levels from the associated customers. As a result, the Health and Engineering reportable segment recognized an impairment charge of $24 million for the quarter and six months ended August 1, 2014 to reduce the carrying value of these intangible assets to their estimated fair values. Fair value was estimated using the income approach based on management's forecast of future cash flows to be derived from the assets' use (Level 3 under the accounting standard for fair value measurement).
The estimated annual amortization expense related to finite-lived intangible assets as of July 3, 2015 was as follows:
Year Ending
 
 
(in millions)
January 1, 2016 (remainder of year)
$
4

Fiscal 2016
8

Fiscal 2017
6

Fiscal 2018
4

Fiscal 2019
2

Fiscal 2020 and thereafter
4

 
$
28

Leidos, Inc.  
Goodwill [Line Items]  
Goodwill and Intangible Assets
Goodwill and Intangible Assets:
The Company's National Security Solutions ("NSS") and Health and Engineering ("HES") reportable segments contain goodwill. The balance and changes in the carrying amount of goodwill by segment were as follows:
 
NSS
 
HES
 
Total
 
(in millions)
Goodwill at January 31, 2014
$
788

 
$
905

 
$
1,693

Goodwill impairment charges

 
(486
)
 
(486
)
Goodwill at January 30, 2015
$
788

 
$
419

 
$
1,207

Adjustments

 

 

Goodwill at July 3, 2015
$
788

 
$
419

 
$
1,207


Goodwill is tested for impairment at the reporting unit level annually, at the beginning of the fourth quarter, and during interim periods whenever events or circumstances indicate that the carrying value may not be recoverable. There were no goodwill impairments during the six months ended July 3, 2015.
During the second quarter ended August 1, 2014, as part of its normal quarterly procedures, the Company considered both qualitative and quantitative factors associated with each of the Company's reporting units and determined that there were indicators that the carrying values of the Health Solutions and Engineering reporting units may not be fully recoverable due to operating performance shortfalls and forecasted declines of revenues and operating income. Based on the unexpected impacts, the Company conducted an interim goodwill impairment test using the two-step quantitative approach.
The Company utilized both the market and income approach as part of the first step of the two-step quantitative goodwill impairment test to determine the estimated fair value of both the Health Solutions and Engineering reporting units (Level 3 fair value measurement).
Based on the first step of the two-step quantitative goodwill impairment test, the Company determined that the fair values of the Health Solutions and Engineering reporting units were below their carrying values. Due to the fact that indicators of impairments existed, the second step of the two-step quantitative goodwill impairment test was performed to determine the implied fair value of goodwill and the impairment amount of the respective reporting units.
As a result of the second step evaluation, the Company recorded goodwill impairment charges in the Health Solutions and Engineering reporting units of $369 million and $117 million, respectively, for the quarter ended August 1, 2014, which represents the difference between the carrying value and the implied fair value. There were no other goodwill impairment charges recorded for the remaining reporting units. No goodwill impairments were identified as part of the Company's annual goodwill impairment evaluation performed in the prior year.
Intangible assets consisted of the following:
 
July 3, 2015
 
January 30, 2015
 
Gross carrying value
 
 Accumulated amortization
 
Net carrying value
 
Gross carrying value
 
Accumulated amortization
 
Net carrying value
 
(in millions)
Finite-lived intangible assets:

 

 

 

 

 

Customer relationships
$
70

 
$
(60
)
 
$
10

 
$
70

 
$
(57
)
 
$
13

Software and technology
61

 
(43
)
 
18

 
52

 
(41
)
 
11

Total finite-lived intangible assets
131

 
(103
)
 
28

 
122

 
(98
)
 
24

Indefinite-lived intangible assets:


 


 


 


 


 


In-process research and development

 

 

 
9

 

 
9

Trade names
4

 

 
4

 
4

 

 
4

Total indefinite-lived intangible assets
4

 

 
4

 
13

 

 
13

Total intangible assets
$
135

 
$
(103
)
 
$
32

 
$
135

 
$
(98
)
 
$
37


The gross carrying value of finite-lived intangible assets increased from January 30, 2015 due to the addition of an in-process research and development intangible asset that reached technological feasibility and began amortizing as a software and technology intangible asset over its useful life of nine years.
Amortization expense related to amortizable intangible assets was $3 million and $5 million for the quarter and six months ended July 3, 2015, respectively, and $5 million and $10 million for the quarter and six months ended August 1, 2014, respectively.
For the quarter ended August 1, 2014, the Company determined that certain customer relationship intangible assets associated with Vitalize and maxIT were not recoverable due to lower projected revenue and operating income levels from the associated customers. As a result, the Health and Engineering reportable segment recognized an impairment charge of $24 million for the quarter and six months ended August 1, 2014 to reduce the carrying value of these intangible assets to their estimated fair values. Fair value was estimated using the income approach based on management's forecast of future cash flows to be derived from the assets' use (Level 3 under the accounting standard for fair value measurement).
The estimated annual amortization expense related to finite-lived intangible assets as of July 3, 2015 was as follows:
Year Ending
 
 
(in millions)
January 1, 2016 (remainder of year)
$
4

Fiscal 2016
8

Fiscal 2017
6

Fiscal 2018
4

Fiscal 2019
2

Fiscal 2020 and thereafter
4

 
$
28